MEMPHIS TN 381632116
Tel: (901) 448-2985

Research Description

Dr. Kovesdy’s research interests are centered on epidemiology and outcomes, cardiovascular risk factors, metabolic abnormalities, race-ethnicity, and bone and mineral disorders in pre-dialysis chronic kidney disease. He is Principal Investigator on several studies and federal grants in these areas. He has published his research in over 200 peer-reviewed articles, as well as numerous abstracts and book chapters. 

Research Keywords

Chronic kidney disease



Progression of CKD


Blood pressure

Cardiovascular risk factors



Bone-mineral metabolism

Research Interest/Specialty

Outcomes in patients with non-dialysis dependent CKD


Clincial trials


  1. Lu JL, Kalantar-Zadeh K, Ma JZ, Quarles LD, Kovesdy CP. Association of Body Mass Index with Outcomes in Patients with CKD. J Am Soc Nephrol, 2014.
  2. Molnar MZ, Kalantar-Zadeh K, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Quarles DL, Kovesdy CP. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol, 7 (63), 650-658, 2014.
  3. Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, Kalantar-Zadeh K, Bleyer AJ. Observational Modeling of Strict vs. Conventional Blood Pressure Control in Patients with Chronic Kidney Disease. JAMA Int Med, 2014.
  4. Kovesdy, CP, Quarles, LD, Lott, EH, Lu, JL, Ma, JZ, Molnar, MZ, Kalantar-Zadeh, K. Survival advantage in black versus white men with CKD: effect of estimated GFR and case mix. Am J Kidney Dis, 62 (2), 228-35, 2013.
  5. Kovesdy, CP, Lott, EH, Lu, JL, Malakauskas, SM, Ma, JZ, Molnar, MZ, Kalantar-Zadeh, K. Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol, 61 (15), 1626-33, 2013.
  6. Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med, 4 (159), 233-42, 2013.
  7. Kovesdy, CP, Lott, EH, Lu, JL, Malakauskas, SM, Ma, JZ, Molnar, MZ, Kalantar-Zadeh, K. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation, 125 (5), 677-84, 2012.
  8. Kovesdy, CP, Lu, JL, Malakauskas, SM, Andress, DL, Kalantar-Zadeh, K, Ahmadzadeh, S. Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial. Am J Kidney Dis, 59 (1), 58-66, 2012.
  9. Kovesdy CP, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Novak M, Kalantar-Zadeh K, Molnar MZ, Mucsi I. Body Mass Index, Waist Circumference and Mortality in Kidney Transplant Recipients. Am J Transplant, 12 (10), 2644-51, 2010.
  10. Kovesdy CP, George SM, Anderson JA, Kalantar-Zadeh K. Outcome-predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr, 2 (90), 407-14, 2009.